High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study
Carregando...
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
CAMPBELL, Christine M. Pierce
FULP, William
GALAN, Lenice
SILVA, Roberto C.
LAZCANO-PONCE, Eduardo
GIULIANO, Anna R.
Citação
BMC INFECTIOUS DISEASES, v.14, article ID 677, 9p, 2014
Resumo
Background: The genital skin of males hosts a diversity of HPV genotypes and uncharacterized HPV genotypes. Previously we demonstrated that a specific viral genotype was not identified in 14% of all genital specimens (i.e., HPV unclassified specimens) using the Roche Linear Array method. Our goal was to identify and assess the prevalence of individual HPV types among genital HPV unclassified specimens collected in the HIM Study population, at enrollment, and examine associations with socio-demographic and behavioral characteristics. Methods: Genital skin specimens of men that were considered unclassified (HPV PCR positive, no genotype specified) at enrollment were typed by sequencing amplified PGMY09/11 products or cloning of PGMY/GP+ nested amplicons followed by sequencing. PGMY/GP+ negative specimens were further analyzed using FAP primers. HPV type classification was conducted through comparisons with sequences in the GenBank database. Results: Readable nucleotide sequences were generated for the majority of previously unclassified specimens (66%), including both characterized (77%) and yet uncharacterized (23%) HPV types. Of the characterized HPV types, most (73%) were Beta [beta]-HPVs, primarily from beta-1 and beta-2 species, followed by Alpha [alpha]-HPVs (20%). Smokers (current and former) were significantly more likely to have an alpha-HPV infection, compared with any other genus; no other factors were associated with specific HPV genera or specific beta-HPV species. Conclusions: Male genital skin harbor a large number of beta-HPV types. Knowledge concerning the prevalence of the diverse HPV types in the men genital is important to better understand the transmission of these viruses.
Palavras-chave
Human papillomavirus, Cutaneous HPV, Males, HIM Study, Prevalence, Prospective study
Referências
- Akogbe GO, 2012, INT J CANCER, V131, pE282, DOI 10.1002/ijc.27397
- Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000
- Astori G, 1998, J INVEST DERMATOL, V110, P752, DOI 10.1046/j.1523-1747.1998.00191.x
- BERKHOUT RJM, 1995, J CLIN MICROBIOL, V33, P690
- Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
- Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383
- Bouvard V, 2009, LANCET ONCOL, V10, P321
- Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090
- Campbell CMP, 2013, J CLIN VIROL, V58, P652, DOI 10.1016/j.jcv.2013.10.011
- Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022
- Chouhy D, 2013, J GEN VIROL, V94, P2480, DOI 10.1099/vir.0.055137-0
- De Roda Husman Ana-Maria, 1995, Journal of General Virology, V76, P1057, DOI 10.1099/0022-1317-76-4-1057
- del Pino M, 2012, MODERN PATHOL, V25, P1354, DOI 10.1038/modpathol.2012.91
- deVilliers EM, 1997, INT J CANCER, V73, P356, DOI 10.1002/(SICI)1097-0215(19971104)73:3<356::AID-IJC9>3.3.CO;2-S
- Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027
- Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204
- Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x
- Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0
- Forslund O, 1999, J GEN VIROL, V80, P2437
- Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031
- Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151
- Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2
- Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020
- Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182
- Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023
- Lindel K, 2009, CANCER INVEST, V27, P781, DOI 10.1080/07357900802653456
- Lu BB, 2009, J INFECT DIS, V199, P362, DOI 10.1086/596050
- Orth G, 2010, B ACAD NAT MED PARIS, V194, P923
- Paolini F, 2013, J CLIN VIROL, V56, P72, DOI 10.1016/j.jcv.2012.09.016
- Partridge JM, 2007, J INFECT DIS, V196, P1128, DOI 10.1086/521192
- Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024
- Sonnex C, 1999, SEX TRANSM INFECT, V75, P317
- Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3
- Viarisio D, 2013, J GEN VIROL, V94, P749, DOI 10.1099/vir.0.048991-0
- Wang J, 2014, J AM ACAD DERMATOL, V70, P621, DOI 10.1016/j.jaad.2014.01.857